Nath Bio Genes India Ltd vs Orkla India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Sep 30, 2026

Key Highlights

The Latest Trading Price of Nath Bio-Genes (India) Ltd is ₹ 142.9 as of 30 Sep 15:30 . The P/E Ratio of Nath Bio-Genes (India) Ltd changed from 7.7 on March 2023 to 0 on March 2026 . This represents a CAGR of -100.00% over 4 yearsThe P/E Ratio of Orkla India Ltd changed from 28 on March 2026 to 28 on March 2026 . This represents a CAGR of 0.00% over 1 years The Market Cap of Nath Bio-Genes (India) Ltd changed from ₹ 405.45 crore on March 2022 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 5 yearsThe Market Cap of Orkla India Ltd changed from ₹ 8010 crore on March 2026 to ₹ 8010 crore on March 2026 . This represents a CAGR of 0.00% over 1 years The revenue of Nath Bio-Genes (India) Ltd for the Jun '26 is ₹ 331.5 crore as compare to the Mar '26 revenue of ₹ 55.23 crore. This represent the growth of 500.22% The revenue of Orkla India Ltd for the Jun '26 is ₹ 678.06 crore as compare to the Mar '26 revenue of ₹ 640.75 crore. This represent the growth of 5.82% The ebitda of Nath Bio-Genes (India) Ltd for the Jun '26 is ₹ 38.25 crore as compare to the Mar '26 ebitda of ₹ 8.11 crore. This represent the growth of 371.64% The ebitda of Orkla India Ltd for the Jun '26 is ₹ 131.49 crore as compare to the Mar '26 ebitda of ₹ 111.14 crore. This represent the growth of 18.31% The net profit of Nath Bio-Genes (India) Ltd changed from ₹ 33.35 crore to ₹ 32.26 crore over 9 quarters. This represents a CAGR of -1.47% The net profit of Orkla India Ltd changed from ₹ 71.91 crore to ₹ 87.7 crore over 9 quarters. This represents a CAGR of 9.22% The Dividend Payout of Nath Bio-Genes (India) Ltd changed from 6.83 % on March 2021 to 0 % on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe Dividend Payout of Orkla India Ltd changed from 236.3 % on March 2025 to 0 % on March 2026 . This represents a CAGR of -100.00% over 2 years .

About Nath Bio-Genes (India) Ltd

Nath Bio-Genes (India) Limited was originally incorporated in the name and style of 'Shivnath Farms Private Limited' as Private Limited Company which thereafter was converted into Public Limited Company on 13 September, 2000 under the name and style of Shivnath Farms Limited' and further changed from Shivnath Farms Limited to Nath Bio-Genes (India) Limited on March 05, 2001. The Company stands as a distinguished leader in the Indian seed industry, leveraging over two decades of expertise in producing and distributing high-quality seeds to Indian farmers.
The Company's robust research and development initiatives have yielded numerous acclaimed cotton seed varieties, noted for their resilience against viruses and weather fluctuations, as evidenced by their outstanding performance in ICAR trials.

About Orkla India Ltd

Orkla India Limited was originally incorporated as 'MTR Foods Limited' as a public limited company, dated August 21, 1996 issued by the RoC. Upon conversion of Company from a public limited company to a private limited company, name was changed to 'MTR Foods Private Limited' and a fresh certificate of incorporation dated November 4, 2008 was issued by the RoC. Thereafter, name was changed to 'Orkla India Private Limited' dated January 4, 2024.
Upon the conversion of Company into a public limited, the name of Company was changed to 'Orkla India Limited', and a fresh certificate of incorporation dated April 25, 2025 was issued by Central Processing Centre.
Company is a subsidiary of Orkla ASA, a Norway-listed industrial, long-term investment company. Orkla India Limited is a multi-category Indian food company offering a diverse range of products to every meal occasion, including breakfast, lunch, snacks, dinner, beverages and desserts.

FAQs for the comparison of Nath Bio-Genes (India) Ltd and Orkla India Ltd

Which company has a larger market capitalization, Nath Bio-Genes (India) Ltd or Orkla India Ltd?

Market cap of Nath Bio-Genes (India) Ltd is 271 Cr while Market cap of Orkla India Ltd is 7,392 Cr

What are the key factors driving the stock performance of Nath Bio-Genes (India) Ltd and Orkla India Ltd?

The stock performance of Nath Bio-Genes (India) Ltd and Orkla India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Nath Bio-Genes (India) Ltd and Orkla India Ltd?

As of September 30, 2026, the Nath Bio-Genes (India) Ltd stock price is INR ₹142.9. On the other hand, Orkla India Ltd stock price is INR ₹539.65.

How do dividend payouts of Nath Bio-Genes (India) Ltd and Orkla India Ltd compare?

To compare the dividend payouts of Nath Bio-Genes (India) Ltd and Orkla India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.